Annual Working Capital
$322.92 M
+$53.70 M+19.95%
31 December 2023
Summary:
Keros Therapeutics annual working capital is currently $322.92 million, with the most recent change of +$53.70 million (+19.95%) on 31 December 2023. During the last 3 years, it has risen by +$62.38 million (+23.94%). KROS annual working capital is now at all-time high.KROS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$523.04 M
+$111.57 M+27.12%
30 September 2024
Summary:
Keros Therapeutics quarterly working capital is currently $523.04 million, with the most recent change of +$111.57 million (+27.12%) on 30 September 2024. Over the past year, it has increased by +$235.31 million (+81.78%). KROS quarterly working capital is now at all-time high.KROS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.9% | +81.8% |
| 3 y3 years | +23.9% | +143.2% |
| 5 y5 years | +2196.4% | - |
KROS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +34.8% | at high | +152.8% |
| 5 y | 5 years | at high | +7171.3% | at high | >+9999.0% |
| alltime | all time | at high | +7171.3% | at high | >+9999.0% |
Keros Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $523.04 M(+27.1%) |
| June 2024 | - | $411.47 M(-7.4%) |
| Mar 2024 | - | $444.41 M(+37.6%) |
| Dec 2023 | $322.92 M(+19.9%) | $322.92 M(+12.2%) |
| Sept 2023 | - | $287.73 M(-9.6%) |
| June 2023 | - | $318.21 M(-8.2%) |
| Mar 2023 | - | $346.76 M(+28.8%) |
| Dec 2022 | $269.22 M | $269.22 M(+14.9%) |
| Sept 2022 | - | $234.35 M(+13.3%) |
| June 2022 | - | $206.90 M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $219.57 M(-8.4%) |
| Dec 2021 | $239.59 M(-8.0%) | $239.59 M(+11.4%) |
| Sept 2021 | - | $215.06 M(-8.0%) |
| June 2021 | - | $233.89 M(-5.3%) |
| Mar 2021 | - | $247.03 M(-5.2%) |
| Dec 2020 | $260.54 M(+5766.7%) | $260.54 M(+101.0%) |
| Sept 2020 | - | $129.59 M(-7.6%) |
| June 2020 | - | $140.22 M(+182.1%) |
| Mar 2020 | - | $49.70 M(+1019.2%) |
| Dec 2019 | $4.44 M(-68.4%) | $4.44 M |
| Dec 2018 | $14.06 M | - |
FAQ
- What is Keros Therapeutics annual working capital?
- What is the all time high annual working capital for Keros Therapeutics?
- What is Keros Therapeutics annual working capital year-on-year change?
- What is Keros Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Keros Therapeutics?
- What is Keros Therapeutics quarterly working capital year-on-year change?
What is Keros Therapeutics annual working capital?
The current annual working capital of KROS is $322.92 M
What is the all time high annual working capital for Keros Therapeutics?
Keros Therapeutics all-time high annual working capital is $322.92 M
What is Keros Therapeutics annual working capital year-on-year change?
Over the past year, KROS annual working capital has changed by +$53.70 M (+19.95%)
What is Keros Therapeutics quarterly working capital?
The current quarterly working capital of KROS is $523.04 M
What is the all time high quarterly working capital for Keros Therapeutics?
Keros Therapeutics all-time high quarterly working capital is $523.04 M
What is Keros Therapeutics quarterly working capital year-on-year change?
Over the past year, KROS quarterly working capital has changed by +$235.31 M (+81.78%)